75,000 Shares in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Purchased by Royce & Associates LP

Royce & Associates LP acquired a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 75,000 shares of the company’s stock, valued at approximately $1,260,000. Royce & Associates LP owned 0.12% of Guardian Pharmacy Services at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Seven Grand Managers LLC purchased a new stake in shares of Guardian Pharmacy Services in the third quarter valued at $2,515,000. Allspring Global Investments Holdings LLC purchased a new stake in Guardian Pharmacy Services in the 3rd quarter worth about $5,460,000. Finally, Stephens Inc. AR purchased a new stake in Guardian Pharmacy Services in the 3rd quarter worth about $189,000.

Guardian Pharmacy Services Price Performance

Shares of NYSE GRDN opened at $21.56 on Wednesday. Guardian Pharmacy Services, Inc. has a 52-week low of $14.16 and a 52-week high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN) last issued its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The business had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. On average, research analysts predict that Guardian Pharmacy Services, Inc. will post 0.81 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on GRDN. Raymond James initiated coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They set an “outperform” rating and a $21.00 target price on the stock. Truist Financial upped their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Finally, Stephens assumed coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price for the company.

Insider Buying and Selling

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of Guardian Pharmacy Services stock in a transaction that occurred on Friday, September 27th. The stock was bought at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the purchase, the director now directly owns 35,714 shares of the company’s stock, valued at approximately $499,996. This represents a ? increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.